查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2080387

動物用藥品市場：2026-2032年全球市場預測（依產品類型、目標動物、給藥途徑、疾病類型、最終用戶和分銷管道分類）

Animal Pharmaceuticals Market by Product Type, Species, Route of Administration, Disease Type, End User, Distribution Channels - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，動物用藥品市場規模將成長至 777.1 億美元，複合年成長率為 8.50%。

主要市場統計數據
基準年 2025 438.8億美元
預計年份：2026年 475.4億美元
預測年份：2032年 777.1億美元
複合年成長率 (%) 8.50%

執行摘要：動物用藥品市場展望

動物用藥品市場受到畜牧業生產力、伴侶動物健康、通用感染疾病防控、抗菌藥物合理使用等多面向因素的影響。動物用藥品，包括驅蟲藥、感染疾病、疫苗、抗發炎藥、皮膚病治療藥物、生殖產品和鎮痛藥，對動物健康、食品安全和公共衛生韌性仍然至關重要。

將重塑獸醫學的變革性變化

競爭格局正從以銷售為導向的治療模式轉向精準預防、合規性生產和數據驅動的獸醫學。隨著禽流感、非洲豬瘟、口蹄疫和其他跨國動物疫病持續影響全球供應鏈，畜牧養殖戶正將疫苗、基於診斷的治療和生物安全計畫列為優先事項。

人工智慧的累積影響

人工智慧 (AI) 在動物用藥品的各個領域都展現出強大的協同效應，包括藥物研發、藥物安全監測、生產品質控制和現場疾病監測。 AI 驅動的建模有助於篩檢化合物、識別不利事件模式、檢測徵兆並最佳化臨床實驗室設計，從而降低漫長研發週期中的不確定性。

動物用藥品的主要區域趨勢

亞太地區是重要的成長引擎，這得益於大規模的畜牧業規模、不斷成長的蛋白質消費、集約化水產養殖以及中國、印度、日本、韓國、澳洲和東協市場不斷發展的獸醫基礎設施。世界動物衛生組織（WHO）和聯合國糧食及農業組織（FAO）的疾病監測持續強調疫苗接種、寄生蟲控制和生物安全在全部區域的重要性。北美仍然是最具創新力的地區之一，這得益於強勁的寵物相關支出、符合美國食品藥品監督管理局（FDA）法規的產品核可流程、較高的寵物保險普及率、完善的分銷網路以及先進的動物衛生體系。

策略市場中的關鍵集團洞察

東協的需求主要由家禽、水產養殖和生豬生產所驅動，生物安全、疫苗供應和獸醫服務是動物健康計畫的核心。海灣合作理事會成員國對糧食安全、駱駝和馬匹護理以及伴侶動物服務的興趣日益濃厚，這得益於對優質獸醫診所、規範的進口管道和品質有保證的藥品供應的需求。

來自主要國家關於動物用藥品的見解

美國在伴侶動物療法、畜牧生技藥品、處方箋管道和監管透明度方面發揮主導作用，這主要得益於美國食品藥物管理局獸醫中心 (FDA CVM) 和美國農業部 (USDA) 的監管。另一方面，加拿大則優先考慮獲得高品質的獸醫服務、動物福利和合理使用抗生素。墨西哥和巴西是畜牧藥品的重要市場，尤其是巴西的牛、家禽和豬產業，對符合出口要求的疫苗、驅蟲藥、育種產品和全畜群健康管理解決方案有著持續的需求。

為行業領導者提供的實用建議

產業領導者應優先考慮差異化的產品系列，並兼顧伴侶動物的專業照護和牲畜的預防保健。這包括疫苗、驅蟲藥、抗發炎療法、皮膚病產品、疼痛管理藥物以及符合合理抗菌藥物使用原則（AMS）的標靶感染疾病物。投資於藥物安全監測、真實世界數據、品管系統和生命週期管理，可以增強監管機構的信任，並提升品牌的永續性。

調查方法

本執行摘要採用系統性的二手資料調查方法，利用了檢驗的資訊來源、監管資料庫、科學文獻、貿易統計數據、獸醫協會出版刊物和動物疾病監測數據。主要參考文獻包括世界動物衛生組織（WOAH）、聯合國糧農組織（FAO）、美國食品藥物管理局（FDA）、美國農業部（USDA）、歐洲藥品管理局（EMA）、各國獸醫主管機關及同行評審期刊等資訊來源。

結論：透過科學、普及和管理實現成長

動物用藥品市場正步入一個更主導實證的階段，其成長取決於創新、管理、可及性和信任。動物用藥品的需求源自於在寵物人性化、蛋白質安全、疾病預防和「同一健康」理念框架下保護動物和人類健康的需要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：動物用藥品市場：依產品類型分類

  • 麻醉劑
  • 抗發炎藥
  • 抗生素
    • Fluoroquinolones抗生素
    • 大環內酯類
    • 青黴素
    • 磺胺類藥物藥物
    • 四環黴素
  • 荷爾蒙和生長調節劑
  • 殺蟲劑
    • 抗寄生蟲藥物
    • 體外寄生蟲控制劑
  • 疫苗
    • 去活化疫苗
    • 減毒活疫苗
    • 次單位疫苗

第8章：動物用藥品市場：依目標動物分類

  • 水生動物
  • 鳥
  • 伴侶動物
    • 貓
    • 狗
    • 馬
  • 家畜
    • 牛
    • 家禽
    • 綿羊和山羊
    • 豬
  • 野生動物

第9章：動物用藥品市場：依給藥途徑分類

  • 口服
    • 膠囊
    • 液體
    • 粉末
    • 藥片
  • 腸外
  • 外用
    • 奶油
    • 軟膏
    • 噴

第10章：動物用藥品市場：依疾病類型分類

  • 感染疾病
    • 細菌感染疾病
    • 黴菌感染疾病
    • 寄生蟲感染疾病
    • 病毒感染疾病
  • 非傳染性疾病
    • 發炎性疾病
    • 代謝性疾病
    • 營養缺乏
    • 生殖障礙

第11章動物用藥品市場：依最終用戶分類

  • 政府和公共衛生組織
  • 畜牧場及家禽養殖場
  • 寵物飼主
  • 研究機構
  • 獸醫醫院和診所

第12章：動物用藥品市場：依通路分類

  • 物理藥房
  • 網路藥房

第13章：動物用藥品市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章動物用藥品市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章動物用藥品市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Aurora Pharmaceutical, Inc.
  • Bimeda Inc.
  • Biogenesis Bago SA
  • Biovac Ltd.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Chanelle Pharma
  • China Animal Husbandry Industry Co., Ltd.
  • Dechra Pharmaceuticals PLC
  • ECO Animal Health Group PLC
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • Huvepharma, Inc.
  • Indian Immunologicals Ltd.
  • Intas Pharmaceuticals Ltd.
  • Laboratorio Drag Pharma Chile Invetec SA
  • Merck & Co., Inc.
  • Neogen Corporation
  • Nippon Zenyaku Kogyo Co., Ltd.
  • Norbrook Group
  • Nutramax Laboratories Veterinary Sciences, Inc
  • Orion Corporation
  • PetIQ, LLC
  • Phibro Animal Health Corporation
  • Teknofarma Srl
  • Veterinary Pharmaceutical Solutions
  • Vetoquinol Group
  • Vetpharma Animal Health SL by Insud Pharma SLU
  • Virbac SA
  • Zendal Group
  • Zoetis Inc.
Product Code: MRR-434CCDA05128

The Animal Pharmaceuticals Market is projected to grow by USD 77.71 billion at a CAGR of 8.50% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 43.88 billion
Estimated Year [2026] USD 47.54 billion
Forecast Year [2032] USD 77.71 billion
CAGR (%) 8.50%

Executive Summary: Animal Pharmaceuticals Market Outlook

The animal pharmaceuticals market is being shaped by the convergence of livestock productivity, companion animal wellness, zoonotic disease preparedness, and antimicrobial stewardship. Veterinary pharmaceuticals, including parasiticides, anti-infectives, vaccines, anti-inflammatory drugs, dermatology therapies, reproductive products, and pain management medicines, remain essential to animal health, food security, and public health resilience.

Verified signals from organizations such as WOAH, FAO, USDA, FDA, and EMA show sustained demand for science-backed medicines that improve animal welfare while reducing disease-related production losses. Growth is strongest where veterinary access, pet insurance adoption, herd health programs, cold-chain capability, and regulatory modernization support earlier diagnosis, preventive care, and responsible treatment.

Transformative Shifts Reshaping Animal Health

The competitive landscape is shifting from volume-led therapeutics toward precision prevention, compliance-ready manufacturing, and data-enabled veterinary care. Livestock producers are prioritizing vaccines, diagnostics-linked treatment, and biosecurity programs as avian influenza, African swine fever, foot-and-mouth disease, and other transboundary animal diseases continue to affect global supply chains.

In companion animals, longer pet lifespans and humanization of pets are expanding demand for chronic care medicines, oncology support, dermatology drugs, pain therapies, and specialty injectables. At the same time, tighter antimicrobial use rules in the United States, European Union, and other regulated markets are accelerating innovation in alternatives such as vaccines, immunomodulators, microbiome products, improved husbandry protocols, and targeted therapeutics.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative force across veterinary drug discovery, pharmacovigilance, manufacturing quality, and field disease surveillance. AI-enabled modeling can help screen compounds, identify adverse event patterns, detect outbreak signals, and optimize clinical study design, reducing uncertainty across long development cycles.

In commercial operations, machine learning is improving demand planning for seasonal parasiticides, biologics cold-chain management, and inventory allocation across veterinary clinics, pharmacies, and livestock channels. The highest-value applications are those paired with validated datasets, regulatory traceability, cybersecurity controls, veterinarian oversight, and explainable models that support, not replace, clinical judgment.

Key Regional Insights in Animal Pharmaceuticals

Asia-Pacific is a major growth engine due to large livestock populations, expanding protein consumption, aquaculture intensity, and rising veterinary infrastructure in China, India, Japan, South Korea, Australia, and ASEAN markets. WOAH and FAO disease monitoring continue to highlight the importance of vaccination, parasite control, and biosecurity across the region. North America remains one of the most innovation-intensive regions, supported by strong companion animal spending, FDA-regulated product pathways, pet insurance penetration, established distribution networks, and advanced livestock health systems.

Europe is defined by strict EMA oversight, One Health policies, and reduced antimicrobial use targets, which favor vaccines, diagnostics-linked treatment, pharmacovigilance, and high-compliance manufacturing. Latin America, led by Brazil and Mexico, benefits from export-oriented cattle, poultry, and swine production, where disease prevention and residue compliance are central to market access. The Middle East is investing in food security, equine and camel health, and premium pet care, while Africa shows long-term potential through livestock vaccination, parasite control, public-sector disease programs, and wider access to essential veterinary medicines.

Key Group Insights Across Strategic Markets

ASEAN demand is influenced by poultry, aquaculture, and swine production, with biosecurity, vaccine access, and veterinary extension becoming central to animal health planning. The GCC is increasingly focused on food security, camel and equine care, and companion animal services, supported by premium veterinary clinics, regulated import pathways, and demand for quality-assured pharmaceutical supply.

The European Union sets a global benchmark for veterinary medicine regulation, pharmacovigilance, residue monitoring, and antimicrobial stewardship under harmonized rules. BRICS countries combine large livestock bases, expanding pet ownership, local manufacturing priorities, and improving veterinary access. G7 markets drive R&D, premium therapeutics, biologics quality standards, and advanced pharmacovigilance, while NATO members generally emphasize supply-chain resilience, disease surveillance, and preparedness for zoonotic and cross-border animal health threats.

Key Country Insights for Veterinary Pharmaceuticals

The United States leads in companion animal therapeutics, livestock biologics, prescription channel development, and regulatory transparency through FDA CVM and USDA oversight, while Canada emphasizes high-quality veterinary access, animal welfare, and responsible antimicrobial use. Mexico and Brazil are important livestock medicine markets, with Brazil's cattle, poultry, and swine industries supporting sustained demand for vaccines, parasiticides, reproductive products, and herd health solutions aligned with export requirements.

The United Kingdom, Germany, France, Italy, and Spain reflect Europe's shift toward stewardship-led prescribing, preventive medicine, and strong pharmacovigilance, while Russia remains tied to domestic livestock production, vaccination programs, and import substitution. China and India are central to Asia's volume growth due to large livestock populations, expanding companion animal care, and evolving regulatory oversight. Japan and South Korea favor premium companion animal care, advanced therapeutics, and high clinical standards, while Australia combines export livestock biosecurity, parasite control, and strong veterinary governance.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize differentiated portfolios that balance companion animal specialty care with livestock prevention, including vaccines, parasiticides, anti-inflammatory therapies, dermatology products, pain management medicines, and targeted anti-infectives aligned with antimicrobial stewardship. Investment in pharmacovigilance, real-world evidence, quality systems, and lifecycle management can strengthen regulatory confidence and brand durability.

Companies should also expand regional manufacturing resilience, cold-chain reliability, veterinarian education, and digital engagement with clinics, pharmacies, and producers. Strategic partnerships with diagnostics providers, universities, contract manufacturers, public health agencies, and animal health distributors can accelerate access while supporting evidence-based use across developed and emerging markets.

Research Methodology

This executive summary applies a structured secondary research methodology using verified public sources, regulatory databases, scientific literature, trade statistics, veterinary association publications, and animal disease surveillance resources. Key references include authorities such as WOAH, FAO, FDA, USDA, EMA, national veterinary agencies, and peer-reviewed journals.

Insights are triangulated across product categories, species segments, regional regulations, supply-chain indicators, disease surveillance data, antimicrobial stewardship policies, and end-user demand patterns. The analysis emphasizes data-backed market signals, policy direction, technology adoption, and commercially relevant shifts without relying on unverified claims, market sizing, market share, or unsupported projections.

Conclusion: Growth Through Science, Access, and Stewardship

The animal pharmaceuticals market is entering a more evidence-driven phase where growth depends on innovation, stewardship, access, and trust. Demand for veterinary medicines is supported by pet humanization, protein security, disease prevention, and the need to protect animal and human health under the One Health framework.

Winning organizations will be those that combine regulatory excellence, AI-enabled intelligence, resilient supply chains, and clinically meaningful products. As regional needs diverge, scalable portfolios, responsible antimicrobial strategies, and localized market access models will be essential to sustained leadership in animal pharmaceuticals.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Animal Pharmaceuticals Market, by Product Type

  • 7.1. Anesthetics
  • 7.2. Anti-Inflammatory Medications
  • 7.3. Antibiotics
    • 7.3.1. Fluoroquinolones
    • 7.3.2. Macrolides
    • 7.3.3. Penicillins
    • 7.3.4. Sulfonamides
    • 7.3.5. Tetracyclines
  • 7.4. Hormones & Growth Regulators
  • 7.5. Parasiticides
    • 7.5.1. Anthelmintics
    • 7.5.2. Ectoparasiticides
  • 7.6. Vaccines
    • 7.6.1. Inactivated Vaccines
    • 7.6.2. Live Attenuated Vaccines
    • 7.6.3. Subunit Vaccines

8. Animal Pharmaceuticals Market, by Species

  • 8.1. Aquatic Animals
  • 8.2. Birds
  • 8.3. Companion Animals
    • 8.3.1. Cats
    • 8.3.2. Dogs
    • 8.3.3. Horses
  • 8.4. Livestock Animals
    • 8.4.1. Cattle
    • 8.4.2. Poultry
    • 8.4.3. Sheep & Goats
    • 8.4.4. Swine
  • 8.5. Wild Animals

9. Animal Pharmaceuticals Market, by Route of Administration

  • 9.1. Oral
    • 9.1.1. Capsules
    • 9.1.2. Liquid solutions
    • 9.1.3. Powders
    • 9.1.4. Tablets
  • 9.2. Parenteral
  • 9.3. Topical
    • 9.3.1. Creams
    • 9.3.2. Ointments
    • 9.3.3. Sprays

10. Animal Pharmaceuticals Market, by Disease Type

  • 10.1. Infectious Diseases
    • 10.1.1. Bacterial Infections
    • 10.1.2. Fungal Infections
    • 10.1.3. Parasitic Infestations
    • 10.1.4. Viral Infections
  • 10.2. Non-Infectious Diseases
    • 10.2.1. Inflammatory Diseases
    • 10.2.2. Metabolic Disorders
    • 10.2.3. Nutritional Deficiencies
    • 10.2.4. Reproductive Disorders

11. Animal Pharmaceuticals Market, by End User

  • 11.1. Government & Public Health Organizations
  • 11.2. Livestock Farms & Poultry Farms
  • 11.3. Pet Owners
  • 11.4. Research Institutions
  • 11.5. Veterinary Clinics & Hospitals

12. Animal Pharmaceuticals Market, by Distribution Channels

  • 12.1. Offline Pharmacies
  • 12.2. Online Pharmacies

13. Animal Pharmaceuticals Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Animal Pharmaceuticals Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Animal Pharmaceuticals Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Aurora Pharmaceutical, Inc.
  • 17.2. Bimeda Inc.
  • 17.3. Biogenesis Bago S.A.
  • 17.4. Biovac Ltd.
  • 17.5. Boehringer Ingelheim International GmbH
  • 17.6. Ceva Sante Animale
  • 17.7. Chanelle Pharma
  • 17.8. China Animal Husbandry Industry Co., Ltd.
  • 17.9. Dechra Pharmaceuticals PLC
  • 17.10. ECO Animal Health Group PLC
  • 17.11. Elanco Animal Health Incorporated
  • 17.12. Hester Biosciences Limited
  • 17.13. Huvepharma, Inc.
  • 17.14. Indian Immunologicals Ltd.
  • 17.15. Intas Pharmaceuticals Ltd.
  • 17.16. Laboratorio Drag Pharma Chile Invetec S.A.
  • 17.17. Merck & Co., Inc.
  • 17.18. Neogen Corporation
  • 17.19. Nippon Zenyaku Kogyo Co., Ltd.
  • 17.20. Norbrook Group
  • 17.21. Nutramax Laboratories Veterinary Sciences, Inc
  • 17.22. Orion Corporation
  • 17.23. PetIQ, LLC
  • 17.24. Phibro Animal Health Corporation
  • 17.25. Teknofarma S.r.l.
  • 17.26. Veterinary Pharmaceutical Solutions
  • 17.27. Vetoquinol Group
  • 17.28. Vetpharma Animal Health S.L. by Insud Pharma S.L.U.
  • 17.29. Virbac S.A.
  • 17.30. Zendal Group
  • 17.31. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL PHARMACEUTICALS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ANIMAL PHARMACEUTICALS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ANIMAL PHARMACEUTICALS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ANIMAL PHARMACEUTICALS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ANIMAL PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANESTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANESTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANTI-INFLAMMATORY MEDICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANTI-INFLAMMATORY MEDICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANTI-INFLAMMATORY MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANTIBIOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MACROLIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MACROLIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MACROLIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PENICILLINS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PENICILLINS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PENICILLINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SULFONAMIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SULFONAMIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SULFONAMIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL TETRACYCLINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL TETRACYCLINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL TETRACYCLINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HORMONES & GROWTH REGULATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HORMONES & GROWTH REGULATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HORMONES & GROWTH REGULATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PARASITICIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PARASITICIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANTHELMINTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANTHELMINTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANTHELMINTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AQUATIC ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AQUATIC ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AQUATIC ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIRDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIRDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIRDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DOGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DOGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HORSES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HORSES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HORSES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SHEEP & GOATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SHEEP & GOATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SHEEP & GOATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL WILD ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL WILD ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL WILD ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CAPSULES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CAPSULES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CAPSULES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL LIQUID SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL LIQUID SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL LIQUID SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL POWDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL POWDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL POWDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL TABLETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL TABLETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PARENTERAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PARENTERAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PARENTERAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CREAMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CREAMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CREAMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL OINTMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL OINTMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL OINTMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL SPRAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL SPRAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL SPRAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL PARASITIC INFESTATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL PARASITIC INFESTATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL PARASITIC INFESTATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL NON-INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL NON-INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL NON-INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL INFLAMMATORY DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL INFLAMMATORY DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL INFLAMMATORY DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL NUTRITIONAL DEFICIENCIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL NUTRITIONAL DEFICIENCIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL NUTRITIONAL DEFICIENCIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL REPRODUCTIVE DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL REPRODUCTIVE DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL REPRODUCTIVE DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL GOVERNMENT & PUBLIC HEALTH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL GOVERNMENT & PUBLIC HEALTH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL GOVERNMENT & PUBLIC HEALTH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL LIVESTOCK FARMS & POULTRY FARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL LIVESTOCK FARMS & POULTRY FARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL LIVESTOCK FARMS & POULTRY FARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL PET OWNERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL PET OWNERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL PET OWNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL VETERINARY CLINICS & HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL VETERINARY CLINICS & HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL VETERINARY CLINICS & HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL OFFLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL OFFLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL OFFLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 190. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 214. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 220. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 244. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 246. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 248. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 252. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 254. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 255. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 258. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 259. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 261. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 262. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 263. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 264. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 265. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 268. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 270. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 271. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 272. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 274. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 275. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 276. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 277. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 278. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 280. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 281. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 282. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 284. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 285. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 287. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 288. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 290. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 291. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 292. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 293. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 294. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 295. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 296. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 297. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 298. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 300. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 301. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 302. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 304. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 306. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 308. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 310. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 312. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 314. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 316. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 317. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 318. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 319. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 320. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 321. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 322. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 323. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 324. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 325. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 326. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 327. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 328. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 329. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 330. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 332. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 333. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 334. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 335. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 336. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 337. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 338. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 339. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 340. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 341. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 342. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 343. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 344. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 345. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 346. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 347. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 348. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 349. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 350. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 351. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 352. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 353. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 354. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 355. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 356. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 357. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 358. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 359. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 360. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 361. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 362. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 363. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 364. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 365. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MI